Premium
CIRCULATING TUMOR DNA IS A PROGNOSTIC BIOMARKER IN CLASSIC HODGKIN LYMPHOMA
Author(s) -
Spina V.,
Pirosa M. C.,
Bruscaggin A.,
Condoluci A.,
Pini K.,
Forestieri G.,
Zangrilli I.,
di Trani M.,
Kurlapski M.,
Moccia A.,
Moia R.,
Bulian P.,
Annunziata S.,
Borsatti E.,
Rodari M.,
Romanowicz G.,
Sacchetti G. M.,
Faderl M.,
Koch R.,
Piffaretti D.,
Terzi di Bergamo L.,
Stasia A.,
Cittone M.,
Chauvie S.,
Stüssi G.,
Gerber B.,
Stathis A.,
Sommer S. Gillessen,
Cavalli F.,
Zucca E.,
Gattei V.,
Zaucha J. M.,
Pinto A.,
Gaidano G.,
CarloStella C.,
Hohaus S.,
Ceriani L.,
Rossi D.
Publication year - 2021
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.70_2879
Subject(s) - medicine , biomarker , oncology , clinical trial , prospective cohort study , liquid biopsy , cancer , lymphoma , biology , biochemistry
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom